Thank you for your interest


Listen to the Podcast below or view a Transcript of the Podcast here



Targeting the Hypoxic Tumor Microenvironment

Cary stephenStephen Cary, Ph.D., Co-Founder & CEO, Omniox

In this podcast from CHI on September 20, 2017, Stephen Carey speaks about Omniox’s quest to deliver oxygen into the tumor microenvironment to improve immunotherapy response. He also remarks on the challenges facing tumor microenvironment research and strategies to overcome them. To see him in person, check out the Targeting the Tumor Microenvironment conference, part of ImPACT: Immunotherapy Progress and Clinical Treatments this December 5-7, 2017 in San Diego, CA.

For more information, please visit ImPACTImmunotherapy.com/Tumor-Microenvironment/